Close
Back to DCPH Stock Lookup

(DCPH) – Hot FDA News

Oct 30, 2023 07:01 AM Deciphera Pharmaceuticals (DCPH) MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor Met Primary Endpoint
Nov 5, 2021 07:01 AM Deciphera Pharmaceuticals (DCPH) INTRIGUE Phase 3 Clinical Study Did Not Meet the Primary Endpoint in GIST
May 15, 2020 03:46 PM
Aug 13, 2019 07:09 AM
Jan 4, 2018 07:01 AM
Nov 20, 2017 07:08 AM
Nov 10, 2017 07:02 AM

Back to DCPH Stock Lookup